medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2007, Number 1

<< Back Next >>

Rev Med UV 2007; 7 (1)

Action plan for the regulation of the usage of trans fatty acids in México

Castillo HJL, Álvarez RMM, Espinosa GR, Herrera LRG, Cervantes OC, Sánchez RC, González AD, Mateu AVS, Acosta CMC, Riaño DAA, Romero HEY, Illescas NI, Rosas NM

Language: Spanish
References: 12
Page: 39-46
PDF size: 324.65 Kb.


ABSTRACT

The participation of the academic institutions as well as the political ones in the elaboration of law proposals, directed to the prevention and control of the illnesses associated with the food consumption is fundamental. For that reason, academics and politicians shared experiences, knowledge and interests to carry out the Action Plan for the regulation and usage of trans-fatty acids in the Food industry in Mexico, through the international Law initiative proposal to regulate the usage of trans-fatty acids in the Food industry: organized by the Nutritionist Faculty of the Universidad Veracruzana of the Fatty Acids Trans in the alimentary industry, organized by the Faculty of Nutrition of the Universidad Veracruzana, in Xalapa, Veracruz. The concept Trans fatty acids was analyzed, the effect on health, the relationship with the chronic-degenerative illnesses, their usage in the alimentary industry as well as in the current legislation. Finally, agreement advances on the carried out gestations in the Senate are presented.


REFERENCES

  1. Grandgirard, A., J. L. Sebedio and J. Fleury 1984. “Geometric isomerization of linolenic acid during heat treatment of vegetable oils”. Journal of the American Oil Chemists Society 61(10): 1563-1568.

  2. Hudgins, L.C., Hirsch, J. y Emken. E.A. 1991. “Correlation of isomeric fatty acids in human adipose tissue with clinical risk factors for cardiovascular disease”. Am. J. Clin. Nutr., Feb; 53(2): 474-82.

  3. Katan MB, Zock PL.1995. “Trans fatty acids and their effects on lipoproteins in humans”. Ann Rev. Nutr. 15:473-493.

  4. Kummerow F.A., Benga G., Ross P., Holmes A. 1983. “Modification of cell membrane composition by dietary lipids and its implications for atherosclerosis” in: Biomembranes and Cell Function, eds: Acad. Sci. Vol. 414, pp. 29-43.

  5. Nestel P., Noakes M., Belling B. 1992. “Plasma lipoprotein and Lp 8 a 9 changes with substitution of elaidic for oleic acid in the diet”. J. Lipid Res. 33: 1029-1033.

  6. Popkin BM. “The nutrition transition and obesity in the developing world”. J Nutr 2001;131(3):871S-873S.

  7. Rivera- Donmarco J., Barquera et al. 2002. “Análisis de la Encuesta Nacional de ingreso y gasto en los hogares (ENIGH), INEGI”, en Public Health Nutrition: 5 (1A), 113-122.

  8. Rocquelin, G., Guenot, L., Justrabo, E., Grynberg, A. David, M. 1985. “Fatty acid composition of human Herat phospholipids: data from 53 biopsy specimens”. J. Mol cell cardiol. Aug:17 (8): 769-73.

  9. Siguel, E.N., Lerman, R.H. 1993. “Trans fatty acid patterns in patients with angiographically docuemented coronary artery disease”. Am J. cardiol, Apr 15; 71(11): 916-20.

  10. Van de Vijver L., P.L, Geert van Poppel, Adriana van Houwelingen, Dick A.C.M, Kruyssen, Gerard Hornstra. 1996. “Trans Unsaturated fatty acids in plasma phospholipids and coronary Herat disease: a case-control study”. ELSEVIER.126. 155-161.

  11. Vásquez, P.F. (2003) (Compilador) Contando nuestros días. Un estudio antropológico de la vejez. Centro de Información y Estudios Superiores en Antropología Social.

  12. Wahrburg U. 2004. “What are the health effects of fat?” Eur. J. Nutr. 43:1/6-1/11.




2020     |     www.medigraphic.com